Literature DB >> 12774043

Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations.

Ana Osorio1, Miguel de la Hoya, Raquel Rodríguez-López, Juan José Granizo, Orland Díez, Ana Vega, Mercedes Durán, Angel Carracedo, Montserrat Baiget, Trinidad Caldés, Javier Benítez.   

Abstract

The BRCA1 gene is included in a 200-400 kb region that is subjected to a recombination suppression mechanism; this region shows nearly complete linkage disequilibrium for a series of common biallelic polymorphisms, all of them with rarer allele frequency close to 0.4. These series of SNPs define two major haplotypes designated as class I and class II. In the present study, we have determined haplotype classes in the index case of 106 breast/ovarian cancer families previously screened for mutations in the BRCA genes and we have found that haplotype II (the less frequent in the control population) is over-represented among chromosomes harbouring mutations in BRCA1. In addition, we have defined a subtype of chromosomes characterized by haplotype I and one specific allele for the microsatellite marker D17S855, which are also more frequently associated with BRCA1 mutations. These findings may have important consequences for the selection of families with higher probabilities of carrying mutations in the BRCA1 gene.

Entities:  

Mesh:

Year:  2003        PMID: 12774043     DOI: 10.1038/sj.ejhg.5200969

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  7 in total

1.  A novel frequent BRCA1 allele in Chinese patients with breast cancer.

Authors:  Dongxian Zhou; Wen Xiong; Hongxan Xu; Chaopeng Shao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

2.  Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.

Authors:  P K Lovelock; S Healey; W Au; E Y M Sum; A Tesoriero; E M Wong; S Hinson; R Brinkworth; A Bekessy; O Diez; L Izatt; E Solomon; M Jenkins; H Renard; J Hopper; P Waring; S V Tavtigian; D Goldgar; G J Lindeman; J E Visvader; F J Couch; B R Henderson; M Southey; G Chenevix-Trench; A B Spurdle; M A Brown
Journal:  J Med Genet       Date:  2005-05-27       Impact factor: 6.318

3.  Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.

Authors:  Jane C Figueiredo; Jennifer D Brooks; David V Conti; Jenny N Poynter; Sharon N Teraoka; Kathleen E Malone; Leslie Bernstein; Won D Lee; David J Duggan; Ashley Siniard; Patrick Concannon; Marinela Capanu; Charles F Lynch; Jørgen H Olsen; Robert W Haile; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2010-12-15       Impact factor: 4.872

4.  A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets.

Authors:  Benjamin D Ward; Brant C Hendrickson; Thaddeus Judkins; Amie M Deffenbaugh; Benoît Leclair; Brian E Ward; Thomas Scholl
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

5.  Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.

Authors:  Lidija Turkovic; Lyle C Gurrin; Melanie Bahlo; Gillian S Dite; Melissa C Southey; John L Hopper
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

6.  Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer.

Authors:  Seyed Mohsen Miresmaeili; Dor Mohammad Kordi Tamandani; Seyed Mehdi Kalantar; Seyed Mohammad Moshtaghioun
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-04

7.  Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer.

Authors:  David G Cox; Peter Kraft; Susan E Hankinson; David J Hunter
Journal:  Breast Cancer Res       Date:  2004-12-16       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.